Glenmark Pharmaceuticals Europe Ltd.

Mucolytic to facilitate expectoration.

• Child 2–4 years: 62.5–125 mg, 4 times daily
• Child 5–11 years: 250 mg, 3 times daily
• Over 12 years: initially 2.25 g daily in divided doses, then 1.5 g daily in divided doses as condition improves

Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1–2 divided doses.
• Adult: 0.5–10 mg daily.

Mild croup by mouth
Child: 150 mcg/kg for 1 dose

Severe croup by mouth
Child: initially 150 mcg/kg before transfer t…

Long-acting selective beta2 agonist with corticosteroid.

Stalpex 500/50 mcg
• For symptomatic treatment of COPD with a FEV1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite re…

For treatment of moderate to severe nasal symptoms associated with allergic rhinitis in adults and adolescents of 12 years of age and older.

• Adults and adolescents of 12 years of age and older: two actuations into each nostril, twice daily

Soprobec is indicated for the maintenance treatment of asthma, when the use of pressurised metered dose inhaler is appropriate.

• Child: 100 mcg twice daily, increased if necessary up to 400 mcg daily in 2–4 divided doses.
• Adult: 200 mcg twice daily, …

For severe asthma in patients 12 years of age and older only where use of a combination product (long-acting beta2 agonist and inhaled corticosteroid) is appropriate: patients not adequately controlled on a lower strength corticosteroid combination p…